Nicholas Holsman | Source | Chief Commercial Officer at Shorla Oncology

Nicholas Holsman

Chief Commercial Officer at Shorla Oncology
On the record
Share profile 
Bio
Edit

As Chief Commercial Officer, Nicholas brings more than 20 years of commercial and launch experience in the fields of virology, cardiovascular and oncology to his role at Shorla Oncology. Over the course of his career, Nicholas has held leadership roles in analytics, market access and commercial operations at pharmaceutical and biotechnology companies. Before joining Shorla Oncology, Nicholas served as Head of Commercial Operations at Oncopeptides, INC. Previously he led Commercial Operations & Market Access at Kempharm and held roles of increasing responsibility at Nextwave Pharmaceuticals, Gilead Sciences & Symphony Health. Nicholas holds a B.A. in Finance from the University of Otago, NZ & B.A. in Architectural Studies from the University of Adelaide, Australia.

Media
Sign up to view all
  • 3 Keys To A Successful Biotech Launch

    Breaking into the big time is a challenge for any young pharma or biotech company, but especially for small startups that have limited resources and a small team — no matter how talented that team might be. This can be complicated further for companies that are not U.S.-based but are looking to launch in the United States. But regardless of where you are based or where you are launching, three of the foundational keys to success in a launch are state licensing, packaging/labeling, and serialization.

    Article
Employment
Sign up to view all